Literature DB >> 7092611

Complications of plasma exchange in neurological patients.

R L Rodnitzky, J A Goeken.   

Abstract

Complications occurred during 154 plasma exchanges performed in 17 patients for a variety of neurological disorders. Mild, self-limited, toxic reaction to citrate was the most frequent complication (7.8%), followed by transient hypotension (2.6%) and visual scotomata (1.3%). More serious complications, occurring on one occasion each, were cardiac arrhythmia, myocardial infarction, and gross hemolysis. There were no infections. The spectrum and frequency of complications in these plasma exchanges were compared with those in other series dealing with both neurological and nonneurological patients. Several risk factors for development of complications were identified, one of the most important being the nature of the illness being treated. The incidence of two of the most serious complications, severe infection and bleeding diathesis, appeared to be higher in patients with renal insufficiency or hematologic disorders, respectively, than in neurological patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092611     DOI: 10.1001/archneur.1982.00510180028007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

Review 1.  [Plasma exchange as a therapeutic option in neurological disorders].

Authors:  H C Lehmann; H P Hartung; G R Hetzel; B C Kieseier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

Review 2.  Anticoagulation techniques in apheresis: from heparin to citrate and beyond.

Authors:  Grace Lee; Gowthami M Arepally
Journal:  J Clin Apher       Date:  2012-04-24       Impact factor: 2.821

3.  Myasthenic crisis.

Authors:  Linda C Wendell; Joshua M Levine
Journal:  Neurohospitalist       Date:  2011-01

4.  [Immunotherapy and infectious issues in multiple sclerosis. Self-injectable and oral drugs for immunotherapy].

Authors:  A Winkelmann; M Löbermann; E C Reisinger; H-P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 5.  Disease-modifying therapies and infectious risks in multiple sclerosis.

Authors:  Alexander Winkelmann; Micha Loebermann; Emil C Reisinger; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2016-03-04       Impact factor: 42.937

6.  Management of acute exacerbations in multiple sclerosis.

Authors:  Daniel Ontaneda; Alex D Rae-Grant
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

7.  Complications of plasma exchange in patients with neurological diseases.

Authors:  T Henze; H W Prange; J Talartschik; K W Rumpf
Journal:  Klin Wochenschr       Date:  1990-12-04

8.  Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Authors:  Jacqueline F Marcus; Emmanuelle L Waubant
Journal:  Neurohospitalist       Date:  2013-04

9.  Comparative efficacy of low dose, daily versus alternate day plasma exchange in severe myasthenia gravis: a randomised trial.

Authors:  Isha Trikha; Sumit Singh; Vinay Goyal; Garima Shukla; Rama Bhasin; Madhuri Behari
Journal:  J Neurol       Date:  2007-08-11       Impact factor: 4.849

Review 10.  Multiple sclerosis treatment and infectious issues: update 2013.

Authors:  A Winkelmann; M Loebermann; E C Reisinger; U K Zettl
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.